NCT01429038View on ClinicalTrials.gov

Mesenchymal Stem Cells After Renal or Liver Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
Liver FailureKidney Failure
Interventions
BIOLOGICAL

Mesenchymal Stem Cells

Third party MSC 1,5-3,010E6/kg. No HLA matching between MSC donor and the recipient or the liver/kidney donor. One infusion at day 3+/-2.

Trial Locations (1)

4000

University Hospital Liege, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT01429038 - Mesenchymal Stem Cells After Renal or Liver Transplantation | Biotech Hunter | Biotech Hunter